The preclinical pharmacology of mephedrone; not just MDMA by another name

Por Green, A R, King, M V, Shortall, S E, Fone, K C F
Publicado em 2014

Fos expression in the orbital prefrontal cortex after exposure to the fixed-interval peak procedure

Por Valencia-Torres, L., Olarte-Sánchez, C.M., Body, S., Fone, K.C.F., Bradshaw, C.M., Szabadi, E.
Publicado em 2012

Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion

Por Body, S., Cheung, T. H. C., Hampson, C. L., den Boon, F. S., Bezzina, G., Fone, K. C. F., Bradshaw, C. M., Szabadi, E.
Publicado em 2008

Fos expression in the prefrontal cortex and ventral striatum after exposure to a free-operant timing schedule

Por Valencia-Torres, L., Olarte-Sánchez, C.M., Body, S., Cheung, T.H.C., Fone, K.C.F., Bradshaw, C.M., Szabadi, E.
Publicado em 2012

-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D(2) Receptors

Por Bay-Richter, C, O'Callaghan, M J, Mathur, N, O'Tuathaigh, C M P, Heery, D M, Fone, K C F, Waddington, J L, Moran, P M
Publicado em 2013